Lanean...
Escitalopram for Major Depression in Parkinson’s Disease: An Open-Label, Flexible-Dosage Study
Depression and antidepressant use are common in Parkinson’s disease, but the benefit of selective serotonin reuptake inhibitor (SSRI) treatment in this population has not been established. The authors treated 14 Parkinson’s disease patients with major depression with escitalopram in an open-label st...
Gorde:
| Egile Nagusiak: | , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2006
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1761053/ https://ncbi.nlm.nih.gov/pubmed/16963587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.neuropsych.18.3.377 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|